{
    "id": "04d836cf-0428-4990-9c09-762c56b08942",
    "indications": "Daptomycin in Sodium Chloride Injection is a lipopeptide antibacterial indicated for the treatment of: • Complicated skin and skin structure infections (cSSSI) in adult and pediatric patients (1 to 17 years of age) for whom appropriate dosing can be achieved ( 1.1 ) and, • Staphylococcus aureus bloodstream infections (bacteremia), in adult patients for whom appropriate dosing can be achieved, including those with right-sided infective endocarditis, ( 1.2 ) • Staphylococcus aureus bloodstream infections (bacteremia) in pediatric patients (1 to 17 years of age) for whom appropriate dosing can be achieved. ( 1.3 ) Limitations of Use • Daptomycin in Sodium Chloride Injection is not indicated for the treatment of pneumonia. ( 1.4 ) • Daptomycin in Sodium Chloride Injection is not indicated for the treatment of left-sided infective endocarditis due to S. aureus. ( 1.4 ) • Daptomycin in Sodium Chloride Injection is not recommended in pediatric patients younger than one year of age due to the risk of potential effects on muscular, neuromuscular, and/or nervous systems (either peripheral and/or central) observed in neonatal dogs. ( 1.4 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of Daptomycin in Sodium Chloride Injection and other antibacterial drugs, Daptomycin in Sodium Chloride Injection should be used to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. ( 1.5 )",
    "contraindications": "If a dose of Daptomycin in Sodium Chloride Injection is required that does not equal 350 mg, 500 mg, 700 mg or 1,000 mg, this product is not recommended for use and an alternative formulation of daptomycin should be considered. ( 2.1 ) Adult Patients • Administer to adult patients intravenously by infusion over a 30-minute period. ( 2.1 , 2.7 ) • Recommended dosage regimen for adult patients ( 2.2 , 2.4 , 2.6 ): Creatinine Clearance (CL CR ) Dosage Regimen cSSSI For 7 to 14 days S. aureus Bacteremia For 2 to 6 weeks ≥30 mL/min 4 mg/kg once every 24 hours 6 mg/kg once every 24 hours <30 mL/min, including hemodialysis and CAPD 4 mg/kg once every 48 hours* 6 mg/kg once every 48 hours* *Administered following hemodialysis on hemodialysis days. Pediatric Patients • Administer to pediatric patients intravenously by infusion over a 30- or 60-minute period, based on age. ( 2.1 , 2.7 ) • Recommended dosage regimen for pediatric patients (1 to 17 years of age) with cSSSI, based on age ( 2.3 ): Age group Dosage* Duration of therapy 12 to 17 years 5 mg/kg once every 24 hours infused over 30 minutes Up to 14 days 7 to 11 years 7 mg/kg once every 24 hours infused over 30 minutes 2 to 6 years 9 mg/kg once every 24 hours infused over 60 minutes 1 to less than 2 years 10 mg/kg once every 24 hours infused over 60 minutes *Recommended dosage is for pediatric patients (1 to 17 years of age) with normal renal function. Dosage adjustment for pediatric patients with renal impairment has not been established. • Recommended dosage regimen for pediatric patients (1 to 17 years of age) with S. aureus bacteremia, based on age ( 2.5 ): Age group Dosage* Duration of therapy 12 to 17 years 7 mg/kg once every 24 hours infused over 30 minutes Up to 42 days 7 to 11 years 9 mg/kg once every 24 hours infused over 30 minutes 1 to 6 years 12 mg/kg once every 24 hours infused over 60 minutes *Recommended dosage is for pediatric patients (1 to 17 years of age) with normal renal function. Dosage adjustment for pediatric patients with renal impairment has not been established.",
    "warningsAndPrecautions": "Daptomycin in Sodium Chloride Injection is supplied as a single-dose premixed frozen isosmotic sterile, nonpyrogenic solution in 50 mL or 100 mL GALAXY plastic containers as follows:\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              Code\n                           \n                           \n                              Product Description\n                           \n                           \n                              NDC Number\n                           \n                        \n                     \n                     \n                        \n                           \n                              2G3593\n                           \n                           \n                              350 milligrams daptomycin in 50 mL (7 mg/mL)\n                              Supplied as 24 bags per carton\n                           \n                           \n                              0338-0712-24\n                           \n                        \n                        \n                           \n                              2G3594\n                           \n                           \n                              500 milligrams daptomycin in 50 mL (10 mg/mL)\n                              Supplied as 24 bags per carton\n                           \n                           \n                              0338-0714-24\n                           \n                        \n                        \n                           \n                              2G3595\n                           \n                           \n                              700 milligrams daptomycin in 100 mL (7 mg/mL)\n                              Supplied as 12 bags per carton\n                           \n                           \n                              0338-0716-12\n                           \n                        \n                        \n                           \n                              2G3596\n                           \n                           \n                              1,000 milligrams daptomycin in 100 mL (10 mg/mL)\n                              Supplied as 12 bags per carton\n                           \n                           \n                              0338-0718-12\n                           \n                        \n                     \n                  \n                  Store in a freezer capable of maintaining a temperature of -20°C (-4°F) or below [see Dosage and Administration (2.7)].\n                  Handle frozen product containers with care. Product containers may be fragile in the frozen state",
    "adverseReactions": "Daptomycin in Sodium Chloride Injection is contraindicated in patients with known hypersensitivity to daptomycin [see Warnings and Precautions (5.1)].",
    "ingredients": [
        {
            "name": "DAPTOMYCIN",
            "code": "NWQ5N31VKK"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE",
            "code": "593YOG76RN"
        },
        {
            "name": "SODIUM PHOSPHATE, DIBASIC, ANHYDROUS",
            "code": "22ADO53M6F"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "organization": "Baxter Healthcare Corporation",
    "name": "Daptomycin in Sodium Chloride",
    "effectiveTime": "20250430"
}